INTERNATIONAL PATENT: DOMAIN THERAPEUTICS FILES APPLICATION FOR "COMBINATIONS OF PAR2 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF CANCER"

GENEVA, Aug. 25 -- DOMAIN THERAPEUTICS (220 Boulevard Gonthier d'Andernach67400 Illkirch-Graffenstaden) filed a patent application (PCT/EP2025/054098) for "COMBINATIONS OF PAR2 INHIBITORS AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF CANCER" on Feb 14, 2025. With publication no. WO/2025/172573, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BRUGAT, Thibaut (220 Boulevard Gonthier d'Andernach67400 Illkirch-Graffenstaden), STAGG, John (Centre hospitalier de l'Universite de Montreal (CHUM)900 rue St-Denis, local R10...